- Home
- INBX vs ESRT Comparison
INBX vs ESRT Comparison
Compare INBX & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | ESRT |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2024 | 2012 |
Fundamental Metrics
Financial Performance| Metric | INBX | ESRT |
|---|---|---|
| Price | $69.47 | $5.28 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 3 |
| Target Price | N/A | ★ $6.77 |
| AVG Volume (30 Days) | 133.4K | ★ 1.8M |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | ★ 649.90 | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $200,000.00 | ★ $768,270,000.00 |
| Revenue This Year | $563.00 | $4.26 |
| Revenue Next Year | N/A | $1.52 |
| P/E Ratio | ★ N/A | $22.14 |
| Revenue Growth | N/A | ★ 0.05 |
| 52 Week Low | $10.81 | $5.53 |
| 52 Week High | $94.57 | $8.76 |
Technical Indicators
Market Signals| Indicator | INBX | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | 24.59 |
| Support Level | $28.54 | N/A |
| Resistance Level | $85.97 | $6.77 |
| Average True Range (ATR) | 4.58 | 0.19 |
| MACD | -1.21 | -0.06 |
| Stochastic Oscillator | 10.10 | 3.11 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.